Objective: Methotrexate (MTX) is a drug used in the treatment of cancer and autoimmune disorders; however, its clinical use is limited because of serious side effects including renal …
H Wu, M Jin, Y Liu, S Wang, C Liu, X Quan… - International Journal of …, 2024 - Elsevier
Triple-negative breast cancer (TNBC) is the most aggressive and fatal subtype of breast cancer with disappointing treatment and high mortality. Tumor microenvironment (TME) …
A Medina-Moreno, MM El-Hammadi… - Drug Delivery and …, 2024 - Springer
Methotrexate successful therapy encounters various challenges in chemotherapy, such as poor oral bioavailability, low specificity, side effects and the development of drug …
E Triantafyllopoulou, DR Perinelli, A Forys, P Pantelis… - Pharmaceutics, 2024 - mdpi.com
Despite the appealing properties of random copolymers, the use of these biomaterials in association with phospholipids is still limited, as several aspects of their performance have …
Prostate cancer (PCa) is characterised by androgen dependency. Unfortunately, under anti- androgen treatment pressure, castration-resistant prostate cancer (CRPC) emerges …
N Aghapur, M Gharbavi, Z Bigdelou, M Zand… - Journal of Drug Delivery …, 2025 - Elsevier
This study aimed to investigate the potential of silver nanoparticles coated with polyvinyl alcohol and conjugated with methotrexate (AgNPs@ PVA-MTX) as a novel therapeutic …
This short note presents the data and rationale for adding five generic non-oncology drugs from general medical practice to gemcitabine, nab-paclitaxel, a current standard cytotoxic …
DT Nguyen, HP Doan, TKN Tran… - Advances in Natural …, 2023 - iopscience.iop.org
In recent years, nanomaterials have been intensively studied and applied in various fields, including pharmaceutical applications. This platform can act as a carrier for anticancer drugs …